Status:

UNKNOWN

Social Determinants of Global Pediatric Diabetes

Lead Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Conditions:

Diabetes Mellitus

Eligibility:

All Genders

Up to 25 years

Brief Summary

There is little data from low-income countries on setting and culture specific perception of childhood diabetes and disease specific stressors including stigma, and how these may affect disease relate...

Detailed Description

Pediatric diabetes is a lifelong condition that affects an estimated 542,000 children under the age of 14 years worldwide, of whom the majority live in low- and middle-income countries. Epidemiologica...

Eligibility Criteria

Inclusion

  • Inclusion criteria for PG1 are age 0-25 years, be of Haitian ancestry defined as having both maternal and paternal grandparents being born in Haiti, have a diagnosis of diabetes, and are enrolled in one of the two study site clinics.
  • Inclusion criteria for PG2 are being the principal caregiver for a PG1.

Exclusion

  • Exclusion criteria for PG1 and PG2 are inability to provide informed consent (if 18 years or older) or inability of a parent or legal guardian to provide informed consent (if younger than 18 years).

Key Trial Info

Start Date :

June 20 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

79 Patients enrolled

Trial Details

Trial ID

NCT04272099

Start Date

June 20 2017

End Date

June 1 2023

Last Update

October 24 2022

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal

Montreal, Quebec, Canada, H1T 2M4

2

CHU Sainte-Justine

Montreal, Quebec, Canada, H3T 1C5

3

Montreal Children's Hospital

Montreal, Quebec, Canada, H4A 3J1

4

Kay Mackenson Pediatric Clinic

Montrouis, Artibonite, Haiti